“Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life”, Bleeding Thromb Vascul Biol, vol. 3, no. 1, Apr. 2024, doi: 10.4081/btvb.2024.104.